Shoulder Replacement Surgeries for Shoulder Osteoarthritis
(SERVASA15 Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the study involves surgical procedures, it's best to discuss your medications with the study team or your doctor.
What data supports the effectiveness of the treatment Reverse Shoulder Arthroplasty for shoulder osteoarthritis?
Is shoulder replacement surgery generally safe for humans?
How does the treatment of reverse shoulder arthroplasty differ from other treatments for shoulder osteoarthritis?
Reverse shoulder arthroplasty (RSA) is unique because it is often used when there is severe shoulder damage or when the rotator cuff (a group of muscles and tendons that stabilize the shoulder) is not functioning properly. Unlike traditional shoulder replacements, RSA provides more stability and is less likely to have complications like glenoid loosening, making it a preferred option for complex shoulder issues.128910
What is the purpose of this trial?
This study will compare total shoulder arthroplasty (TSA) with an augmented glenoid component and reverse shoulder arthroplasty (RSA) procedures, in participants with advanced glenohumeral osteoarthritis aged 65 years and older, who also present with greater than 15 degrees of glenoid retroversion, in the context of a prospective, randomized controlled trial to determine the optimal treatment in this patient population.
Research Team
Peter Lapner, MD
Principal Investigator
The Ottawa Hospital
Eligibility Criteria
This trial is for people aged 65 and older with advanced shoulder osteoarthritis and a specific bone condition (over 15 degrees of glenoid retroversion). They must have tried standard treatments like painkillers, physiotherapy, and lifestyle changes for at least six months without success. Those who've had previous shoulder surgery or suffer from certain other conditions can't join.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo either Total Shoulder Arthroplasty (TSA) with an augmented glenoid component or Reverse Shoulder Arthroplasty (RSA) procedure
Follow-up
Participants are monitored for safety, effectiveness, and quality of life outcomes post-surgery
Long-term Follow-up
Participants' long-term outcomes are assessed, including quality of life and component survivorship
Treatment Details
Interventions
- Reverse Shoulder Arthroplasty
- Total Shoulder Arthroplasty + augmented glenoid component
Reverse Shoulder Arthroplasty is already approved in European Union, United States, Canada for the following indications:
- Massive rotator cuff tears
- Irreparable rotator cuff tears
- Severe shoulder arthritis
- Massive rotator cuff tears
- Irreparable rotator cuff tears
- Severe shoulder arthritis
- Failed rotator cuff repair
- Massive rotator cuff tears
- Irreparable rotator cuff tears
- Severe shoulder arthritis
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor